Angiographic and physiologic assessment of coronary flow and myocardial perfusion in the cardiac catheterization laboratory

Acute Cardiac Care

Volumn 10, Issue 2, 2008, Pages 69-78

  Vijayalakshmi, Kunadian ^a   De Belder, Mark A ^a  

^a JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Coronary flow; Coronary flow reserve; Fractional flow reserve; TIMI flow grade; TIMI frame count

Indexed keywords

ANGIOCARDIOGRAPHY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY FLOW RESERVE; DIGITAL SUBTRACTION ANGIOGRAPHY; DOPPLER ECHOCARDIOGRAPHY; FRACTIONAL FLOW RESERVE; HEART CATHETERIZATION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY;

CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY DISEASE; HEART CATHETERIZATION; HUMANS; LABORATORIES, HOSPITAL; REGIONAL BLOOD FLOW;

EID: 45849083108     PISSN: 17482941     EISSN: 1748295X     Source Type: Journal    
DOI: 10.1080/17482940701606905     Document Type: Review

References (48)

1. Heberden W. Commentaries on the History and Cure of Diseases 1802.
2. Gould K, Lipscomb K, Hamilton G. Physiologic basis for assessing critical coronary stenosis: instantaneous flow response and regional distribution during coronary hyperaemia as measure of coronary flow reserve. Am J Cardiol. 1974;33:87-94.
3. Marcus M, Chilian W, Kanatsuka H, Dellsperger K, Eaatham C, Lamping K. Understanding the coronary circulation through studies at the microvascular level. Circulation. 1990;81:1-7.
4. The TIMI Study Group. Thrombolysis in Myocardial Infarction (TIMI) trial. N E J Med. 1985;312:932-6.
5. Ross A, Neuhaus K, Ellis S. Frequent lack of correspondence among core laboratories in assessing TIMI flow grade after reperfusion therapy. Circulation. 1995;92:I-345.
6. The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function and survival after acute myocardial infarction. N Engl J Med. 1993;329:1615-22.
7. Gibson CM, Cannon C, Daley W, Dodge JTJ, Alexander B, Marble S, et al. TIMI Frame Count: A Quantitative Method of Assessing Coronary Artery Flow. Circulation. 1996;93:879-88.
8. Tanedo J, Kelly R, Marquez M, Burns D, Klein L, Costanzo M, et al. Assessing coronary blood flow dynamics with the TIMI frame count method: Comparison with simultaneous intracoronary doppler and ultrasound. Catheter Cardiovasc Interv. 2001;53:459-63.
9. Vijayalakshmi K, Ashton V, Wright R, Hall J, Stewart M, Davies A, et al. Corrected TIMI frame count: Applicability in modern digital catheter laboratories when different frame acquisition rates are used. Catheter Cardiovasc Interv. 2004;63:426-32.
10. Al Mousa ENM, Dodge JTJ, Rizzo M, McLean C, Moynihan J, Kelley M, et al. Thrombolysis in Myocardial Infarction frame count in saphenous vein grafts. Am Heart J. 1998;135:323-8.
11. Faile B, Guzzo J, Tate D, Nichols T, Smith S, Dehmer G. Effect of sex, hemodynamics, body size, and other clinical variables on the corrected thrombolysis in myocardial infarction frame count used as an assessment of coronary blood flow. Am Heart J. 2000;140:308-14.
12. Abac A, Oguzhan A, Eryol N, Ergin A. Effect of Potential Confounding Factors on the Thrombolysis in Myocardial Infarction (TIMI) Trial Frame Count and Its Reproducibility. Circulation. 1999;100:2219-23.
13. Cannon C, McCabe C, Diver D. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: Results of the thrombolysis in myocardial infarction (TIMI) 4 trial. JACC 1994;24:1602-10.
14. Cannon C, McCabe C, Gibson CM. TNK-tissue plasminogen activator in acute myocadial infarction: Results of the thrombolysis in myocardial infarction (TIMI) 10A dose-ranging trial. Circulation. 1997;95:351-6.
15. Amos DJ, French JK, Andrews J, Ashton NG, Williams BF, Whitlock RM, et al. Corrected TIMI frame counts correlate with stenosis severity and infarct zone wall motion after thrombolytic therapy. Am Heart J. 2001;141:586-91.
16. Gibson C, Murphy S, Rizzo M. Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Circulation. 1999;99:1945-50.
17. Gibson CM. Angioplasty guidewire velocity: A new simple method to calculate absolute coronary blood velocity and flow. Am J Cardiol. 1997;80:1536-9.
18. Stankovic G, Manginas A, Voudris V, Pavlides G, Athanassopoulos G, Ostojic M, et al. Prediction of restenosis after coronary angioplasty by use of a new index: TIMI frame count/minimal luminal diameter ratio. Circulation. 2000;101:962-8.
19. Stoel MG, Zijlstra F, Visser CA. Frame count reserve. Circulation. 2003;107:3034-9.
20. Tobis JM, Mallery J, Mahon D, Lehmann K, Zalesky P, Griffith J, et al. Intravascular ultrasound imaging of human coronary arteries in vivo. Analysis of tissue characterizations with comparison to in vitro histological specimens. Circulation. 1991;83:913-26.
21. Nissen SE, Gurley JC, Grines CL, Booth DC, McClure R, Berk M, et al. Intravascular ultrasound assessment of lumen size and wall morphology in normal subjects and patients with coronary artery disease. Circulation. 1991;84:1087-99.
22. Nissen SE, Yock P. Intravascular ultrasound: novel pathophysiological insights and current clinical applications. Circulation. 2001;103:604-16.
23. Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T, Hori M, et al. Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation. 1996;93:223-8.
24. Ito H, Okamura A, Iwakura K, Masuyama T, Hori M, Takiuchi S, et al. Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation. 1996;93:1993-9.
25. Gibson C. www.timi.org. The TIMI study group 2006. 26. van't Hof A, Liem A, Suryapranata H, Hoorntje J, de Boer M, Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction. Circulation. 1998;97:2302-6.
26. Cannon CP, Gibson CM, McCabe CH, Adgey AA, Schweiger MJ, Sequeira RF, et al. TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in myocardial infarction (TIMI) 10B investigators. Circulation. 1998;98:2805-14.
27. Gibson CM, de Lemos JA, Murphy SA, Marble SJ, Dauterman KW, Michaels A, et al. Methodologic and clinical validation of the TIMI myocardial perfusion grade in acute myocardial infarction. J Thromb Thrombolysis. 2002;14:233-7.
28. Murphy S, Chen C, Gourlay SG. Impaired tissue level perfusion in the non-culprit artery territory in the setting of acute MI. Am J Cardiol. 2003;91:325-8.
29. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 1987;316:1371-5.
30. Kern MJ, Lerman A, Bech JW, De Bruyne B, Eeckhout E, Fearon WF, et al. Physiological assessment of coronary artery disease in the cardiac catheterization laboratory: a scientific statement from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology. Circulation. 2006;114:1321-41.
31. Doucette J, Corl P, Payne H. Validation of Doppler guide wire for intravascular measurements of coronary artery flow velocity. Circulation. 1992;85:1899-1.
32. Serruys PW, di Mario C, Piek J, Schroeder E, Vrints C, Probst P, et al. Prognostic value of intracoronary flow velocity and diameter stenosis in assessing the short- and long-term outcomes of coronary balloon angioplasty: the DEBATE Study (Doppler endpoints balloon angioplasty trial Europe). Circulation. 1997;96:3369-77.
33. Chamuleau SA, Tio RA, de Cock CC, de Muinck ED, Pijls NH, van Eck-Smit BL, et al. Prognostic value of coronary blood flow velocity and myocardial perfusion in intermediate coronary narrowings and multivessel disease. J Am Coll Cardiol. 2002;39:852-8.
34. Caiati C, Montaldo C, Zedda N, Bina A, Iliceto S. New noninvasive method for coronary flow reserve assessment: contrast-enhanced transthoracic second harmonic echo Doppler. Circulation. 1999;99:771-8.
35. Caiati C, Montaldo C, Zedda N, Montisci R, Ruscazio M, Lai G, et al. Validation of a new noninvasive method (contrast-enhanced transthoracic second harmonic echo Doppler) for the evaluation of coronary flow reserve: comparison with intracoronary Doppler flow wire. J Am Coll Cardiol. 1999;34:1193-200.
36. Caiati C, Zedda N, Montaldo C, Montisci R, Iliceto S. Contrast-enhanced transthoracic second harmonic echo Doppler with adenosine: a noninvasive, rapid and effective method for coronary flow reserve assessment. J Am Coll Cardiol. 1999;34:122-30.
37. Pijls NH, van Gelder B, Van der V, Peels K, Bracke FA, Bonnier HJ, et al. Fractional flow reserve. A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation. 1995;92:3183-93.
38. Pijls NH, De Bruyne B, Peels K, Van der V, Bonnier HJ, Bartunek JKJ, et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med. 1996;334:1703-8.
39. Pijls NH, van Son JA, Kirkeeide RL, De Bruyne B, Gould KL. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation. 1993;87:1354-67.
40. Hanekamp CE, Koolen JJ, Pijls NH, Michels HR, Bonnier HJ. Comparison of quantitative coronary angiography, intravascular ultrasound, and coronary pressure measurement to assess optimum stent deployment. Circulation. 1999;99:1015-21.
41. Chamuleau SA, Meuwissen M, Koch KT, van Eck-Smit BL, Tio RA, Tijssen JG, et al. Usefulness of fractional flow reserve for risk stratification of patients with multivessel coronary artery disease and an intermediate stenosis. Am J Cardiol. 2002;89:377-80.
42. Wongpraparut N, Yalamanchili V, Pasnoori V, Satran A, Chandra M, Masden R, et al. Thirty-month outcome after fractional flow reserve-guided versus conventional multivessel percutaneous coronary intervention. Am J Cardiol. 2005;96:877-84.
43. Umman B, Nisanci Y, Sezer M, Umman S, Yilmaz E, Oflaz H, et al. The relationship between corrected TIMI frame count and myocardial fractional flow reserve. J Invasive Cardiol. 2002;14:125-8.
44. Pijls NH, de Bruyne B, Smith L, Aarnoudse W, Barbato E, Bartunek J, et al. Coronary thermodilution to assess flow reserve: validation in humans. Circulation. 2002;105:2482-6.
45. Fearon WF, Balsam LB, Farouque HM, Caffarelli AD, Robbins RC, Fitzgerald PJ, et al. Novel index for invasively assessing the coronary microcirculation. Circulation. 2003;107:3129-32.
46. Aarnoudse W, van den BP, van der V, Geven M, Rutten M, Van TM, et al. Myocardial resistance assessed by guidewire-based pressure-temperature measurement: in vitro validation. Catheter Cardiovasc Interv. 2004;62:56-63.
47. Ng MK, Yeung AC, Fearon WF. Invasive assessment of the coronary microcirculation: superior reproducibility and less hemodynamic dependence of index of microcirculatory resistance compared with coronary flow reserve. Circulation. 2006;113:2054-61.
48. Siebes M, Verhoeff BJ, Meuwissen M, de Winter RJ, Spaan JA, Piek JJ. Single-wire pressure and flow velocity measurement to quantify coronary stenosis hemodynamics and effects of percutaneous interventions. Circulation. 2004;109:756-62.